Caxton Associates (New York)’s Inovalon Holdings, Inc. Class A Common Stock INOV Stock Holding History
Bought
Maintained
Sold
Other funds holding INOV
BCIM
BCA
RP
PVI
TM
Caxton Associates (New York)'s INOV Position: Q4 2020 in Review
Caxton Associates (New York) sold out of Inovalon Holdings, Inc. Class A Common Stock (INOV) in Q4 2020, closing a stake of 17,472 shares — an estimated $462K sold.
Caxton Associates (New York) first reported a position in INOV in Q3 2019 and held it in 5 quarters. The position peaked at $631K in Q2 2020. 174 funds tracked by Wall St. Rank hold INOV as of Q4 2020.
- Caxton Associates (New York) reported no remaining Inovalon Holdings, Inc. Class A Common Stock position as of Q4 2020 after selling out during the quarter.
- Caxton Associates (New York) sold 17,472 Inovalon Holdings, Inc. Class A Common Stock shares in Q4 2020, an estimated $462K.
- Caxton Associates (New York) first reported a position in Inovalon Holdings, Inc. Class A Common Stock in Q3 2019 and held it in 5 quarters.
- Caxton Associates (New York)'s Inovalon Holdings, Inc. Class A Common Stock position peaked at $631K in Q2 2020.
- 174 funds tracked by Wall St. Rank held Inovalon Holdings, Inc. Class A Common Stock as of Q4 2020.
Based on Caxton Associates (New York)'s 13F filing for Q4 2020, filed 16 Feb 2021.